Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence.

Fagerström Consulting, Jordkull 3670, 26878 Kagerod, Sweden.
Nicotine & Tobacco Research (Impact Factor: 2.48). 01/2012; 14(1):75-8. DOI: 10.1093/ntr/ntr137
Source: PubMed
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Zusammenfassung: Die chronisch obstruktive Lungenerkrankung (chronic obstructive pulmonary disease, abgekürzt: COPD) ist eine der weltweit führenden Todesursachen. Das Rauchen ist die mit Abstand häufigste Ursache der COPD. Der Verzicht auf Tabakrauchen ist deswegen die effektivste Einzelmaßnahme und zentraler Aspekt der Prävention der COPD. Zum Thema COPD sind mehrere Leitlinien publiziert, die bereits zu Prävention, Diagnostik, Therapie und Rehabilitation Stellung nehmen. Um eine Standardisierung und Etablierung der Tabakentwöhnung flächendeckend in Deutschland zu gewährleisten, wurde im Jahr 2008 aufgrund der Komplexität des Themas eine eigene Leitlinie zur Tabakentwöhnung bei COPD entwickelt. Die vorliegende Fassung ist ein Update dieser Leitlinie Tabakentwöhnung bei COPD unter Berücksichtigung aktueller Erkenntnisse und Forschungsergebnisse. Aufgabe der S3-Leitlinie ist es, die Tabakentwöhnung bei Patienten mit COPD als zentralen Aspekt der Therapie ausführlich und praxisnah abzubilden. Abstract: Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide. Cigarette smoking is the main cause of COPD. Quitting smoking is thus the most effective treatment strategy and central in COPD prevention. A number of guidelines on prevention, diagnosis, therapy and rehabilitation of COPD have been published. To help implementing and standardizing smoking cessation in COPD a guideline was published 2008 in Germany focusing on this complex issue. The present guideline is an update of the 2008 guideline and has a high grade of evidence (S3 according to the AWMF; Arbeitsgemeinschaft wissenschaftlicher medizinischer Fachgesellschaften). The guideline gives comprehensive and practical information on how to integrate smoking cessation as an central part of COPD therapy.
    Pneumologie 01/2014; 68(04):237‐ 258.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Tobacco use remains the number one cause of preventable chronic disease and death in developed countries worldwide. In North America, smoking rates are highest among young adults. Despite that the majority of young adult smokers indicate wanting to quit, smoking rates among this age demographic have yet to decline. Helping young adults quit smoking continues to be a public health priority. Digital mobile technology presents a promising medium for reaching this population with smoking cessation interventions, especially because young adults are the heaviest users of this technology. Objective: The primary aim of this trial is to determine the effectiveness of an evidence-informed mobile phone app for smoking cessation, Crush the Crave, on reducing smoking prevalence among young adult smokers.
    JMIR Research Protocols. 01/2015; 4(1):e10.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Currently, there is an intensive debate about the regulation of the use of electronic cigarettes (e-cigarettes) in indoor places. The aim of this study was to assess the attitudes toward e-cigarette use in indoor workplaces and selected public and private venues among the general population in Barcelona (Spain) in 2013-2014. This is a cross-sectional study of a representative sample of the population of Barcelona (n = 736). The field work was conducted between May 2013 and February 2014. We computed the prevalence and the adjusted odds ratios (OR) derived from multivariable logistic regression models. The awareness of e-cigarettes was 82.3%. Forty five percent of respondents did not agree with the use of e-cigarettes in public places and 52.3% in workplaces. The proportion of disapproval of the use of e-cigarettes in indoor places was higher at 71.5% for schools and 65.8% for hospitals and health care centers; while the prevalence of disapproval of e-cigarette use in homes and cars was lower (18.0% and 32.5%, respectively). Respondents who disagreed on the use of e-cigarettes in indoor workplaces were more likely to be older (OR = 1.64 and 1.97 for groups 45-64 and ≧65 years old, respectively), those with a high educational level (OR = 1.60), and never and former smokers (OR = 2.34 and 2.16, respectively). Increased scores in the Fagerström test for cigarette dependence were also related to increased support for their use. Based on this population based study, half of the general population of Barcelona does not support the use of e-cigarettes in indoor workplaces and public places, with the percentage reaching 65% for use in schools, hospitals and health care centers. Consequently, there is good societal support in Spain for the politicians and legislators to promote policies restricting e-cigarettes use in workplaces and public places, including hospitality venues.
    PLoS ONE 12/2014; 9(12):e114256. · 3.53 Impact Factor


Available from
Dec 11, 2014